You are here

  • Home
  • Archive
  • Volume 93, Issue Suppl 2
  • O05.3 A phase ii, randomised, study in adult subjects evaluating the efficacy, safety, and tolerability of single doses of gepotidacin (GSK2140944) for treatment of uncomplicated urogenital gonorrhoea

Article metrics

Article menu

Download PDFPDF

Neisseria gonorrhoeae
O05.3 A phase ii, randomised, study in adult subjects evaluating the efficacy, safety, and tolerability of single doses of gepotidacin (GSK2140944) for treatment of uncomplicated urogenital gonorrhoea
Free

 

Online download statistics by month:

Online download statistics by month: July 2017 to March 2024

AbstractFullPdf
Jul 20171604
Aug 20172603
Sep 20171800
Oct 20173201
Nov 20173001
Dec 20176002
Jan 20188200
Feb 20186001
Mar 20188401
Apr 201815206
May 201810600
Jun 20184801
Jul 20183400
Aug 20184404
Sep 20182202
Oct 20182203
Nov 20183002
Dec 20182600
Jan 20192602
Feb 20191801
Mar 20192503
Apr 20192208
May 20191202
Jun 2019403
Jul 20191302
Aug 2019803
Sep 20192002
Oct 20191902
Nov 20191003
Dec 20191601
Jan 20201401
Feb 2020401
Mar 20201606
Apr 20201602
May 2020800
Jun 2020603
Jul 2020601
Aug 20201405
Sep 20201200
Oct 202044013
Nov 20201606
Dec 20201101
Jan 2021802
Feb 2021401
Mar 2021903
Apr 2021804
May 20211404
Jun 2021001
Jul 2021005
Aug 2021103
Sep 2021003
Oct 20216012
Nov 202128013
Dec 20211001
Jan 20221602
Feb 2022600
Mar 20221604
Apr 20221802
May 20221007
Jun 20222406
Jul 2022600
Aug 2022802
Sep 20221005
Oct 2022804
Nov 20221406
Dec 20222005
Jan 2023704
Feb 2023402
Mar 20231400
Apr 2023202
May 20231005
Jul 20234010
Aug 2023204
Oct 2023604
Nov 20232002
Dec 20231403
Jan 2024402
Feb 2024401
Mar 20241003
Total15970239